GSK3B and Alzheimer disease: In AD, there are studies supporting GSK-3 activity increased (Hye et al., 2005; Leroy et al., 2007), and the activated GSK-3β is accumulated in a subpopulation of neurons with NFTs in the AD brains (Pei et al., 1999).